AP
GILD icon

Advisortrust Partners’s Gilead Sciences GILD Stock Holding History

Advisortrust Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Buy
2,845
+137
+5% +$18.1K 0.12% 137
2026
Q1 		$377K Buy
2,708
+153
+6% +$21.4K 0.16% 110
2025
Q4 		$314K Buy
+2,555
New +$311K 0.14% 112

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Advisortrust Partners's GILD Position: Q2 2026 in Review

Advisortrust Partners increased its Gilead Sciences (GILD) stake by 5.1% in Q2 2026, buying an estimated $18.1K and bringing the position to 2,845 shares worth $359K. The position accounts for 0.12% of the portfolio, ranked #137.

Advisortrust Partners first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $377K in Q1 2026. 2,261 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Advisortrust Partners held 2,845 shares of Gilead Sciences worth $359K as of Q2 2026.
  • Advisortrust Partners bought 137 Gilead Sciences shares in Q2 2026, an estimated $18.1K.
  • Gilead Sciences made up 0.12% of Advisortrust Partners's portfolio in Q2 2026, its #137 holding.
  • Advisortrust Partners first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Advisortrust Partners's Gilead Sciences position peaked at $377K in Q1 2026.
  • 2,261 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Advisortrust Partners's 13F filing for Q2 2026, filed 10 Aug 2026.